These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Bluetongue vaccination in Europe. Zientara S; MacLachlan NJ; Calistri P; Sanchez-Vizcaino JM; Savini G Expert Rev Vaccines; 2010 Sep; 9(9):989-91. PubMed ID: 20822340 [No Abstract] [Full Text] [Related]
4. Bluetongue vaccines. Noad R; Roy P Vaccine; 2009 Nov; 27 Suppl 4():D86-9. PubMed ID: 19837295 [TBL] [Abstract][Full Text] [Related]
5. Prospects for improved bluetongue vaccines. Roy P; Boyce M; Noad R Nat Rev Microbiol; 2009 Feb; 7(2):120-8. PubMed ID: 19148179 [TBL] [Abstract][Full Text] [Related]
6. Vaccines for bluetongue and other orbiviruses from a regulatory viewpoint. Strating A Prog Clin Biol Res; 1985; 178():627-9. PubMed ID: 2989911 [No Abstract] [Full Text] [Related]
7. [Vaccination against bluetongue serotype 8 in the Netherlands]. Kuijk H; Jansen M; Moulin V; Makoschey B Tijdschr Diergeneeskd; 2008 Dec; 133(23):1006-9. PubMed ID: 19133439 [No Abstract] [Full Text] [Related]
8. Re: Detection of bluetongue virus genome after vaccination with an inactivated vaccine. Eschbaumer M; Wäckerlin R; Hoffmann B; Beer M Vaccine; 2010 Jan; 28(4):881-2. PubMed ID: 19925907 [No Abstract] [Full Text] [Related]
9. Bluetongue--where are we now? Oura C Vet Rec; 2008 Oct; 163(16):491. PubMed ID: 18931359 [No Abstract] [Full Text] [Related]
10. Efficacy of three inactivated vaccines against bluetongue virus serotype 8 in sheep. Eschbaumer M; Hoffmann B; König P; Teifke JP; Gethmann JM; Conraths FJ; Probst C; Mettenleiter TC; Beer M Vaccine; 2009 Jun; 27(31):4169-75. PubMed ID: 19406189 [TBL] [Abstract][Full Text] [Related]
12. The current status of research on an experimental inactivated bluetongue virus vaccine. Stott JL; Osburn BI; Barber TL Proc Annu Meet U S Anim Health Assoc; 1979; (83):55-62. PubMed ID: 233389 [No Abstract] [Full Text] [Related]
13. Use of a quadrivalent modified-live bluetongue virus vaccine in wildlife species. McConnell S; Morrill JC; Livingston CW Prog Clin Biol Res; 1985; 178():631-8. PubMed ID: 2989912 [TBL] [Abstract][Full Text] [Related]
14. Neutralising antibody responses in cattle and sheep following booster vaccination with two commercial inactivated bluetongue virus serotype 8 vaccines. Bartram DJ; Heasman L; Batten CA; Oura CA; Plana-Durán J; Yuen HM; Wylie AD Vet J; 2011 May; 188(2):193-6. PubMed ID: 20466568 [TBL] [Abstract][Full Text] [Related]
15. Vaccines against bluetongue in Europe. Savini G; MacLachlan NJ; Sanchez-Vizcaino JM; Zientara S Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):101-20. PubMed ID: 17765305 [TBL] [Abstract][Full Text] [Related]
16. Immune responses and protective efficacy of binary ethylenimine (BEI)-inactivated bluetongue virus vaccines in sheep. Ramakrishnan MA; Pandey AB; Singh KP; Singh R; Nandi S; Mehrotra ML Vet Res Commun; 2006 Nov; 30(8):873-80. PubMed ID: 17139537 [No Abstract] [Full Text] [Related]
17. Use of bluetongue vaccine in Scotland. Bartram D Vet Rec; 2008 Nov; 163(21):638. PubMed ID: 19029114 [No Abstract] [Full Text] [Related]
18. Differentiation between field and vaccine strain of bluetongue virus serotype 16. Monaco F; Cammà C; Serini S; Savini G Vet Microbiol; 2006 Aug; 116(1-3):45-52. PubMed ID: 16713688 [TBL] [Abstract][Full Text] [Related]
19. Scientific study of bluetongue vaccine uptake and efficacy. Wood J; Webb C; Oura C Vet Rec; 2008 Jun; 162(25):831. PubMed ID: 18567937 [No Abstract] [Full Text] [Related]